Laurence Albiges

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Laurence Albiges
Sep 10, 2024, 14:54 | Blog
Tom Powles: Belzutifan for clear cell renal cancer
Tom Powles shared a post on X: “Belzutifan significantly outperformed Everolimus in heavily pretreated clear…
Aug 27, 2024, 19:10 | Blog
Petros Grivas: Looking forward to a fantastic ESMO24
Petros Grivas shared a post on X by ESMO, adding: "Looking forward to a fantastic…
Aug 25, 2024, 14:05 | Blog
Petros Grivas: Can’t wait for amazing Uromigos meeting!
Petros Grivas shared a post on X by Uromigos adding: "Can’t wait for amazing Uromigos…
Aug 25, 2024, 13:02 | Insight
Toni Choueiri: Results from LITESPARK-005 are out
Toni Choueiri shared a post on X about a recent paper titled "Belzutifan versus Everolimus…
Aug 24, 2024, 05:36 | Insight
Roberto Iacovelli: Proud of being part of this achievement in renal cancer
Roberto Iacovelli shared on X: “I am so proud of being part of this achievement…
Aug 23, 2024, 11:39 | Opinion
Toni K. Choueiri: LITESPARK-005 is out
Toni K. Choueiri shared on LinkedIn: “LITESPARK-005 is out in NEJM Group —First in class…
Aug 9, 2024, 02:02 | Insight
ASCO24 Abstracts Not To Miss by Earle Burgess
Earle Burgess, Genitourinary Medical Oncologist at Atrium Health, Levine Cancer Institute, recently shared posts on…
Aug 2, 2024, 23:33 | Blog
Renee Maria Saliby: Discussing a huge clinical unmet - non-clear cell RCC
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post by GU…
Jul 13, 2024, 20:46 | Blog
Yüksel Ürün: Outstanding presentation at KCRS24 Rohit Mehra
Yüksel Ürün shared on X: "Outstanding presentation at KCRS 24 Rohit Mehra Role of Pathologist…
Jul 13, 2024, 12:22 | Insight
Key Highlights from KCRS24 by Sumanta K. Pal
Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in Boston focused…
Jun 26, 2024, 03:43 | Blog
Roberto Iacovelli: Honour to have TIDE-A commented by Laurence Albiges, Tom Powles and Dr. Wells
Roberto Iacovelli shared a post on X: "Great honor to have TIDE-A commented by Laurence…
Jun 13, 2024, 07:21 | Blog
Sumanta K. Pal: Looking forward to joining Roger Li and Vikram M. Narayan for a quick ASCO24 update
Sumanta K. Pal shared a post on X: "Looking forward to joining Roger Li and Vikram…
Jun 9, 2024, 02:45 | Insight
Brian Rini: KIM-1 is a novel prognostic and predictive biomarker in RCC
Toni Choueiri shared a post by Brian Rini, Chief of Clinical Trials at Vanderbilt University, on X/Twitter:…
May 29, 2024, 12:36 | Blog
Cristiane D. Bergerot: Looking forward to Laurence Albiges ' presentation at  ASCO24
Cristiane D. Bergerot shared on X/Twitter: "Looking forward to Laurence Albiges' presentation at ASCO24 on…
May 28, 2024, 07:49 | Insight
Tom Powles: Renal cancer highlights at ASCO24 - KIM1 biomarker data stands out
Toni Choueiri shared a post by Tom Powles, Director of Barts Cancer Center, on X and…
May 25, 2024, 07:09 | Societies
Neeraj Agarwal summarizes some Abstracts of ASCO24
Neeraj Agarwal shared on X: Abstract #5010 by Michael Morris Phase 1 study of Actinium-225-labeled…
Feb 2, 2024, 17:53 | Blog
Laurence Albiges: Proud of Gustave Roussy GU group celebrating 20th anniversary GU24  
Laurence Albiges, Chair at Medical Oncology Department at Gustave Roussy, shared a post on X/Twitter:…
Feb 1, 2024, 17:14 | Insight
Sumanta K. Pal: She has developed what I think should be called the 'Bergerot QOL Index ' for kidney cancer
Sumanta K. Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared…
Jan 29, 2024, 17:32 | Insight
David Braun: Could really change how nivo is delivered in the future
David Braun, Oncologist, physician-scientist at Yale Cancer Center, shared a post on X/Twitter: "Really nice…
Dec 12, 2023, 12:40 | Societies
20 Posts Not To Miss From ESMO Asia Congress 2023
The ESMO Asia Congress 2023 took place in Singapore from 1 to 3 December. Our…
Oct 22, 2023, 00:11 | Blog
Maite Bourlon: Press release on CheckMate-67T study of subcutaneous Nivolumab while The European Society for Medical Oncology (ESMO) begins
Maite Bourlon, Urology Oncologist at the National Institute of Medical Sciences and Nutrition Salvador Zubirán,…
All: 21 Posts: 1 - 100
Special Coverage